Free Trial
LON:IBT

International Biotechnology (IBT) Share Price, News & Analysis

International Biotechnology logo
GBX 630 -2.00 (-0.32%)
As of 11:46 AM Eastern

About International Biotechnology Stock (LON:IBT)

Key Stats

Today's Range
624
643.30
50-Day Range
480
694
52-Week Range
480
736
Volume
73,483 shs
Average Volume
78,386 shs
Market Capitalization
£226.30 million
P/E Ratio
6.01
Dividend Yield
4.60%
Price Target
N/A
Consensus Rating
N/A

Company Overview

The Company’s investment objective is to achieve long-term capital growth by investing in biotechnology and other life sciences companies. The Company will seek to achieve its objective by investing in a diversified portfolio of companies which may be quoted or unquoted and whose shares are considered to have good growth prospects, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology. Investments may also be made in related sectors such as medical devices and healthcare services. While the Company’s portfolio is held as one pool of assets, for operational purposes there is a quoted portfolio and an unquoted portfolio. The portfolio is diversified by geography, industry sub-sector and investment size with no single investment in a company normally accounting for more than 15% of the portfolio at the time of investment. The portfolio is split between large, mid and small-capitalisation companies, primarily quoted on stock exchanges in North America, where the most established and commercial biotech and other life sciences companies and companies operating in related sectors are based, though investments will also be made in Europe, Asia and Australia. Investments may also be made into unquoted companies and into funds not quoted on a stock exchange, including venture capital funds. This may include funds managed by the Investment Manager and/or members of its group. The primary purpose of investment in unquoted funds will be to gain exposure to unquoted companies. The Company may invest through equities, index-linked securities and debt securities, cash deposits, money market instruments and foreign currency exchange transactions. Forward or derivative transactions are not used by the Company. The Company may borrow from time to time to exploit specific investment opportunities, rather than to apply long-term structural gearing to the Company’s portfolio of investments.

Receive IBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for International Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

IBT Stock News Headlines

Donald Trump is about to free crypto from its chains …
Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election … surpassing $100,000 on Dec. 8 .… Now Juan believes it could hit $150,000 … or higher in 2025.
See More Headlines

IBT Stock Analysis - Frequently Asked Questions

International Biotechnology's stock was trading at GBX 682 at the beginning of 2025. Since then, IBT shares have decreased by 7.6% and is now trading at GBX 630.
View the best growth stocks for 2025 here
.

International Biotechnology (LON:IBT) issued its quarterly earnings results on Tuesday, November, 5th. The company reported ($9.16) earnings per share (EPS) for the quarter. International Biotechnology had a net margin of 90.66% and a trailing twelve-month return on equity of 13.67%.

Shares of IBT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that International Biotechnology investors own include Vanquis Banking Group (PFG), 1724525 (ADN.L) (ADN), abrdn New India Investment Trust (ANII), The Berkeley Group (BKG), GLI Finance (GLIF), Hurricane Energy (HUR) and Oxford Pharmascience Group (OXP).

Company Calendar

Last Earnings
11/05/2024
Today
5/02/2025

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Asset Management
Sub-Industry
N/A
Current Symbol
LON:IBT
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
6.02
Forward P/E Ratio
668.21
P/E Growth
N/A
Net Income
£37.91 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£41.82 million
Cash Flow
GBX 4.05 per share
Price / Cash Flow
155.74
Book Value
GBX 766.24 per share
Price / Book
0.82

Miscellaneous

Free Float
N/A
Market Cap
£226.49 million
Optionable
Not Optionable
Beta
0.21
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (LON:IBT) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners